Here, we use genome-scale CRISPR/Cas9 screening in human cells and identify myeloid-associated differentiation marker (MYADM) as an essential host factor for PeV-A1, PeV-A2 and PeV-A3 infection. This evidence concerns the gene MYADM and infection.